Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitomycin C with 5-FU/FA in Metastatic GI Cancer
NCT00289445Phase 2Completed
- Sponsor
- University Hospital Tübingen
- Start
- Sep 1999
- Primary completion
- Mar 2006
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of mitomycin c in gastrointestinal cancer and colorectal cancer (CRC), sponsored by University Hospital Tübingen. Primary endpoints: Maximum Tolerated Dose, Toxicity and 1 more. Started Sep 1999; status: completed.
02
Drugs
mitomycin c
03
Conditions
gastrointestinal cancercolorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00289445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289445.